Immediate Effect of Needling at CV-12 (Zhongwan) Acupuncture Point on Blood Glucose Level in Patients with Type 2 Diabetes Mellitus: A Pilot Randomized Placebo Controlled Trial
Conclusion The result of this study suggests that 30 minutes of needling at CV-12 might be useful in reducing blood glucose level in patients with T2DM.
Authors: Shan PF, Li Q, Khamaisi M, Qiang GF PMID: 29230243 [PubMed]
Weight loss (WL) and altered gut hormonal levels are involved in glucose homeostasis after laparoscopic sleeve gastrectomy (LSG).
Authors: Huang H, Shetty S, Bauer E, Lang K Abstract OBJECTIVE: To estimate the proportion of patients with moderate to severe chronic kidney disease (CKD) whose initial DPP4-i dosage was concordant with prescribing information (label) recommendations in the United States. METHODS: Adult patients with T2DM who initiated a DPP4-i (linagliptin, sitagliptin, saxagliptin) between Jan 1, 2011 and Jun 30, 2014 were identified using electronic medical records and administrative claims, with index date being the date of first observed DPP4-i treatment. Patients were required to have CKD Stage 3b, 4 or 5 (eGFR value
Conditions: NAFLD; Diabetes Mellitus, Type 2; Hypertriglyceridemia; Fatty Liver, Nonalcoholic Interventions: Drug: ISIS 703802; Drug: Placebo Sponsors: Ionis Pharmaceuticals, Inc.; Akcea Therapeutics Not yet recruiting
Authors: Bazargan-Hejazi S, Arroyo JS, Hsia S, Brojeni NR, Pan D Abstract Objective: To investigate: 1) the racial/ethnic disparities in meeting the recommended physical activity as measured by subjective vs objective measures in a national sample of individuals with type 2 diabetes mellitus; and 2) the racial/ethnic differences with respect to the magnitude of the discrepancy between self-reported and objectively measured moderate-to-vigorous intensity aerobic physical activity (MVPA). Methods: We used data from the National Health and Nutrition Examination Survey (NHANES) 2003-06 to calculate and compare the ...
To examine cardiac biomarkers over time in youth-onset type 2 diabetes, and relate serum concentrations to cardiovascular disease risk factors, and left ventricular structure and function.
The incidence of cardiovascular disease is more than three times higher in patients with diabetes than in those without [1 –3]. The East–West study has shown that the incidence of myocardial infarction (MI) in patients with diabetes and without a history of MI was similar to that of non-diabetic patients with a history of MI . In addition, follow-up studies such as the subgroup analysis in the Action in Diabetes and Vascular disease: preterax and diamicron-MR Controlled Evaluation (ADVANCE) study revealed that albuminuria and a decrease in estimated glomerular filtration rate (eGFR) are further independent r...
In this study, we...
The “Diabetes and Atherosclerotic Cardiovascular Disease” issue of the Endocrinology and Metabolism Clinics of North America is dedicated to a rapidly evolving field of great importance for physicians caring for patients with or at risk for diabetes mellitus. The guest editor is Dr Guillermo E. Umpi errez, a renowned diabetologist and prolific investigator at Emory University. Dr Umpierrez is an expert in management of inpatient hyperglycemia and senior author of the recent American Association of Clinical Endocrinologists consensus statement with regards to treatment of type 2 diabetes.
In conclusion, our data suggest that miR‐221 promotes white adipose tissue inflammation and decreases insulin sensitivity in obesity, at least in part, through suppressing SIRT1. This article is protected by copyright. All rights reserved